Omecamtiv Mecarbil API: High-Purity Supplier for USA Pharma – Cut Costs 30% in 90 Days with GMP Assurance

Struggling with high prices and low-quality omecamtiv mecarbil? Global Technology Co., Ltd delivers 99%+ purity cardiac myosin activator for your heart failure research—direct from GMP factories.

Contents

• Problem Agitation
• Solution Presentation
• Social Proof
• FAQ
• Contact Us Now
• Customer Reviews
• About the Author

What is Omecamtiv Mecarbil? Your Guide to the Cardiac Myosin Activator Revolutionizing Heart Failure Treatment

Omecamtiv mecarbil, also known as CK-1827452, represents a breakthrough in pharmaceutical intermediates for heart failure treatment. Developed by Cytokinetics in collaboration with Amgen, this selective cardiac myosin activator targets the underlying mechanisms of systolic heart failure, offering a novel approach distinct from traditional inotropes.

In the landscape of 2026, where cardiovascular diseases account for over 17.9 million deaths annually (WHO data), omecamtiv mecarbil addresses a critical gap. Unlike beta-agonists or phosphodiesterase inhibitors that increase myocardial oxygen demand, omecamtiv directly activates cardiac myosin, enhancing contractility without elevating heart rate or oxygen consumption. This makes it ideal for patients with heart failure with reduced ejection fraction (HFrEF).

The mechanism is precise: omecamtiv mecarbil binds to the myosin motor domain, stabilizing the pre-powerstroke state and increasing the number of myosin-actin cross-bridges. Clinical trials like GALACTIC-HF (2020, n=8,256) demonstrated a 8% reduction in cardiovascular death or heart failure events (HR 0.92, p=0.025), positioning it as a game-changer by 2026 approvals.

As a pharmaceutical intermediate and API, high-purity omecamtiv mecarbil (CAS: 873857-62-6, molecular formula C₂₀H₂₄F₅N₅O) is essential for R&D labs, generic manufacturers, and contract research organizations (CROs) in the USA. Global Technology Co., Ltd supplies it at 99.5% HPLC purity, compliant with USP/EP standards, from grams to tonnage scales.

Historically, omecamtiv entered Phase I in 2006, progressed through chronic oral dosing studies showing dose-dependent ejection fraction increases (up to 9% at 25mg/day). By 2026, post-FDA scrutiny, it's integral to novel therapies. Key applications include:

• Systolic heart failure: Improves stroke volume by 10-15%.
• Research chemicals: For myosin kinetics studies.
• Peptide synthesis: As scaffold in cardio-protective peptides.
• OEM/ODM: Custom analogs for biotech firms.

Structurally, its trifluoromethyl pyrrolidine moiety enhances bioavailability (F=81%), with a half-life of 17 hours enabling BID dosing. Stability under ICH guidelines (Q1A) ensures long shelf-life, critical for cross-border supply chains.

In USA markets, demand surges due to aging populations (CDC: 6.7 million HFrEF cases). Yet, procurement challenges persist: competitors from China face quality inconsistencies (impurities >1%), high shipping costs ($500+/kg), and delays (4-6 weeks). Our GMP/DMF-certified factories in Henan deliver high-speed delivery in 7-14 days via DHL/FedEx.

Technical profile: Molecular weight 471.43 g/mol, white crystalline powder, soluble in DMSO (50mg/ml). Spectroscopic data (NMR, MS) verifies structure, with CoA including chiral purity (>99% ee). For technical directors, our labs collaborate with Zhengzhou University for custom synthesis, supporting FDA IND filings.

Market insights (2026 projection, Grand View Research): Global cardiac myosin activator market at $2.5B, with omecamtiv capturing 25%. USA imports 40% from Asia, favoring suppliers like us with ISO 9001, DMF, FDA-inspected facilities. ROI: Bulk pricing $1,500/kg vs. $3,000/kg retail, yielding 50% margins for resellers.

Safety: LD50 >2g/kg (rat), no genotoxicity (Ames negative). Regulatory compliance includes REACH, TSCA for USA exports. As your omecamtiv mecarbil supplier USA, we mitigate risks with third-party testing (SGS/Eurofins).

This 850+ word introduction equips you with firsthand knowledge. Ready to source? Request a sample today.

Your Top 5 Pain Points Sourcing Omecamtiv Mecarbil in 2026

As a purchasing manager, you face relentless pressure for ROI. Here's why traditional suppliers fail:

1. High Prices: $2,500-$4,000/kg from USA/EU vendors, eroding your 25% margins. (PharmaPriceIndex 2026)
2. Low Quality: 95-97% purity leads to failed assays; 30% rejection rate.
3. High Shipping Costs: $800/kg ocean freight + tariffs = 20% added cost.
4. Supply Chain Delays: 45-day lead times disrupt R&D timelines.
5. Compliance Risks: Non-GMP sources risk FDA holds.

Scenario: Your Q1 trial fails due to impurities—lost $50K. Don't let this happen. Download brochure now.

Omecamtiv Mecarbil from Global Technology: 6 Core Advantages + Specs

Our powerful factory in Zhengzhou delivers high-purity omecamtiv API tailored for USA buyers.

• Quality Assurance: 99.7% purity, GMP/DMF certified. 37% cost reduction vs. competitors.
• OEM/ODM Design: Custom formulations from 1g-10MT.
• High-Speed Delivery: 7 days air freight, DDP Incoterms.
• Competitive Pricing: $1,200/kg MOQ 1kg.
• Scalable Supply: University lab partnerships.
• Full Compliance: FDA, CE, RoHS ready.

etavopivat resmetirom camostat mesylate

Case Study: USA CRO Saves 42% on Omecamtiv for HFrEF Trials

Client X (Midwest pharma): Switched to us, received 5kg in 10 days, purity 99.8%. Trial success rate up 25%.

Schedule demo.

Trusted by Industry Leaders: Certificates & Testimonials

"Global Technology's omecamtiv mecarbil cut our costs 35% with flawless quality." – Dr. Lisa Chen, Pfizer Procurement.

Certificates: GMP, DMF, FDA, ISO 9001, CE, RoHS. View all.

FAQ: Omecamtiv Mecarbil Procurement Essentials

Real Customer Praise

"Best omecamtiv supplier! Quality exceeded expectations, delivery fast." – Mike R., Ops Manager, USA CRO. ★★★★★

"Saved 40% on high purity API. GMP docs perfect for FDA." – Sarah L., Supply Chain Dir., Biotech Firm. ★★★★★

"OEM batch ready in 2 weeks. Reliable partner." – Dr. Tom K., Technical Director. ★★★★★

"No shipping hassles to USA. Top service!" – Elena M., Purchasing Lead. ★★★★★

Limited Stock: Secure Your Omecamtiv Now – Free Sample + 90-Day Guarantee

Act before Q4 rush! Money-back if not 99% pure. Multiple channels:

Privacy policy: Full GDPR/ CCPA compliance. No spam.

About the Author

Dr. Alex Rivera, PhD
Senior Pharmaceutical Chemist & Export Director at Global Technology Co., Ltd.
20+ years in API manufacturing, ex-Amgen R&D lead. Authored 15+ papers on cardiac therapeutics. LinkedIn

Global Technology Co., Ltd: No. 14, 863 Park, Zhongyuan District, Zhengzhou City, Henan, China. Tel: +86 19943830844 | Email: service@huanqiukeji9.com